electroCore, Inc.
ECOR4.740USD
-0.210-4.24%
Handelsschluss 11/05, 16:00（ET）Kurse um 15 Minuten verzögert
35.39MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über electroCore, Inc. Unternehmen
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company. It provides non-invasive vagus nerve stimulation (nVNS) technology platform. The Company’s product categories include Handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and Handheld, personal use consumer products utilizing nVNS technology to promote general wellness and human performance. Its products include gammaCore, Truvaga and TAC-STIM. Its gammaCore Sapphire, is a prescription medical device that is used for a variety of primary headache conditions. Its Truvaga is a personal use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com. The Company’s TAC-STIM product is not a medical device and is not intended to diagnose, cure, mitigate, prevent, or treat a disease or condition.
electroCore, Inc. Informationen
BörsenkürzelECOR
Name des UnternehmenselectroCore, Inc.
IPO-datumJun 22, 2018
CEOMr. Daniel S. Goldberger
Anzahl der mitarbeiter73
WertpapierartOrdinary Share
GeschäftsjahresendeJun 22
Addresse200 Forge Way
StadtROCKAWAY
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl07866
Telefon19732900097
Websitehttps://www.electrocore.com/
BörsenkürzelECOR
IPO-datumJun 22, 2018
CEOMr. Daniel S. Goldberger
Führungskräfte von electroCore, Inc.
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Daniel S. (Dan) Goldberger
Mr. Daniel S. (Dan) Goldberger
Chief Executive Officer, Director
Chief Executive Officer, Director
184.90K
+0.54%
Mr. Thomas M. (Tom) Patton, J.D.
Mr. Thomas M. (Tom) Patton, J.D.
Independent Director
Independent Director
102.78K
+22.69%
Mr. John P. Gandolfo
Mr. John P. Gandolfo
Independent Director
Independent Director
88.10K
+27.52%
Ms. Patricia Wilber
Ms. Patricia Wilber
Independent Director
Independent Director
72.33K
+35.66%
Ms. Elena Bonfiglioli
Ms. Elena Bonfiglioli
Director
Director
30.55K
--
Dr. Thomas J. Errico, M.D.
Dr. Thomas J. Errico, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Joshua S. Lev
Mr. Joshua S. Lev
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Julie A. Goldstein
Ms. Julie A. Goldstein
Independent Director
Independent Director
--
--
Mr. James C. Theofilos
Mr. James C. Theofilos
Director
Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Daniel S. (Dan) Goldberger
Mr. Daniel S. (Dan) Goldberger
Chief Executive Officer, Director
Chief Executive Officer, Director
184.90K
+0.54%
Mr. Thomas M. (Tom) Patton, J.D.
Mr. Thomas M. (Tom) Patton, J.D.
Independent Director
Independent Director
102.78K
+22.69%
Mr. John P. Gandolfo
Mr. John P. Gandolfo
Independent Director
Independent Director
88.10K
+27.52%
Ms. Patricia Wilber
Ms. Patricia Wilber
Independent Director
Independent Director
72.33K
+35.66%
Ms. Elena Bonfiglioli
Ms. Elena Bonfiglioli
Director
Director
30.55K
--
Dr. Thomas J. Errico, M.D.
Dr. Thomas J. Errico, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Rx gammaCore - Department of Veteran Affairs and Department of Defense
5.18M
70.25%
Truvaga
994.00K
13.47%
Outside the United States
465.00K
6.30%
Rx gammaCore - U.S. Commercial
394.00K
5.34%
TAC-STIM
181.00K
2.45%
Andere
162.00K
2.19%
Nach RegionUSD
Name
Umsatz
Anteil
United States
6.89M
93.42%
United Kingdom
433.00K
5.87%
Other
36.00K
0.49%
Japan
17.00K
0.23%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Rx gammaCore - Department of Veteran Affairs and Department of Defense
5.18M
70.25%
Truvaga
994.00K
13.47%
Outside the United States
465.00K
6.30%
Rx gammaCore - U.S. Commercial
394.00K
5.34%
TAC-STIM
181.00K
2.45%
Andere
162.00K
2.19%
Aktionärsstatistik
Aktualisiert: Sun, Sep 14
Aktualisiert: Sun, Sep 14
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Zhang (Tianyi)
9.19%
Theofilos (Charles Steve)
5.56%
Hilve Holdings Ltd
5.40%
Errico (Thomas J.)
3.83%
AWM Investment Company, Inc.
3.38%
Andere
72.64%
Aktionäre
Aktionäre
Anteil
Zhang (Tianyi)
9.19%
Theofilos (Charles Steve)
5.56%
Hilve Holdings Ltd
5.40%
Errico (Thomas J.)
3.83%
AWM Investment Company, Inc.
3.38%
Andere
72.64%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
26.98%
Corporation
8.76%
Investment Advisor
7.19%
Investment Advisor/Hedge Fund
4.70%
Hedge Fund
2.52%
Research Firm
0.24%
Pension Fund
0.03%
Andere
49.58%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
70
1.17M
14.68%
-263.78K
2025Q2
83
3.54M
47.26%
+919.62K
2025Q1
79
2.97M
41.24%
+583.46K
2024Q4
81
2.54M
38.89%
+127.67K
2024Q3
72
2.68M
41.45%
+353.98K
2024Q2
75
2.58M
42.20%
+349.71K
2024Q1
80
2.10M
35.02%
-224.03K
2023Q4
78
2.23M
37.11%
+633.96K
2023Q3
84
2.11M
37.42%
+276.86K
2023Q2
89
1.49M
31.36%
-816.60K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Zhang (Tianyi)
734.64K
9.25%
+734.64K
--
May 15, 2025
Theofilos (Charles Steve)
444.53K
5.6%
--
--
Jul 04, 2025
Hilve Holdings Ltd
432.00K
5.44%
+432.00K
--
Aug 15, 2025
Errico (Thomas J.)
306.38K
3.86%
+26.61K
+9.51%
Sep 02, 2025
AWM Investment Company, Inc.
269.93K
3.4%
-48.18K
-15.15%
Jun 30, 2025
The Vanguard Group, Inc.
232.33K
2.92%
--
--
Jun 30, 2025
Goldberger (Daniel S)
184.90K
2.33%
+1.00K
+0.54%
Aug 11, 2025
Renaissance Technologies LLC
180.69K
2.27%
+2.26K
+1.27%
Jun 30, 2025
Happy Holstein Management, LLC
153.17K
1.93%
--
--
Jul 04, 2025
MAZ Partners, L.P.
115.52K
1.45%
-156.44K
-57.52%
May 13, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sun, Nov 2
Aktualisiert: Sun, Nov 2
Name
Anteil
iShares Micro-Cap ETF
0.01%
iShares Micro-Cap ETF
Anteil0.01%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Datum
Art
Verhältnis
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
